Vico Therapeutics
- Business Model
- B2B
- Website
- vicotx.com
- Total Funding
- $103.0M
- Last Round
- $12.0M Extension RoundJun 2024
- Rounds
- 3
About
Vico Therapeutics is a neurology genetic medicine company developing antisense oligonucleotide treatments for rare neurological diseases.
Summary
Vico Therapeutics is a Biotech company. It has raised $103.0M in total across 3 rounds, most recently a $12.0M Extension Round round in Jun 2024. Investors include Kurma Partners, Seroba Life Sciences and LSP.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...